(Q39460822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2877854%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

review article

1 reference

title

Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2877854%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

0 references

T Pullar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2877854%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

H A Capell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2877854%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

language of work or name

1 reference

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2877854%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2877854%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

32 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2877854%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

54-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2877854%20AND%20SRC:MED&resulttype=core&format=json

Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy

6 October 2019

cites work

1 reference

12 December 2020

Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity

1 reference

12 December 2020

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

1 reference

12 December 2020

The assessment of disease activity in rheumatoid arthritis using a multivariate analysis

1 reference

12 December 2020

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

1 reference

12 December 2020

The effect of the acetylator phenotype on the metabolism of sulphasalazine in man

1 reference

12 December 2020

Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects

1 reference

12 December 2020

Salazopyrin in the Treatment of Rheumatoid Arthritis

1 reference

12 December 2020

Salazopyrin in rheumatoid arthritis

1 reference

12 December 2020

Sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

Acetylator phenotype in spontaneous SLE and rheumatoid arthritis

1 reference

12 December 2020

Clinical responses during gold therapy for rheumatoid arthritis. Changes in synovitis, radiologically detectable erosive lesions, serum proteins, and serologic abnormalities

1 reference

12 December 2020

Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate

1 reference

12 December 2020

An improved and simplified method of detecting the acetylator phenotype

1 reference

12 December 2020

Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes

1 reference

12 December 2020

Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine

1 reference

12 December 2020

A biochemical assessment of sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

1 reference

12 December 2020